The Venture Codex Logo

The Venture Codex

Promethera Biosciences

Watson & Crick Hill Rue Granbonpré, 11, Mont-Saint-Guibert, Brabant Wallon, 1435, Belgium

Overview

Biopharmaceutical company developing cell therapies for liver diseases.

Total Raised

$138 M

Rounds

8

Links

Verticals

Biotechnology
Pharmaceutical
Therapeutics

Investment History

  1. Series D

    May 2019

    $45M

    Korea Investment PartnersITOCHU Corporation · LeadMitsui & Co. Global InvestmentShinsei Capital Partners · LeadMEDIPAL HOLDINGS CORPORATION

  2. Convertible Note

    Apr 2018

    $11M

    Shibuya CorporationShinsei Corporate Investment

  3. Series C

    Oct 2016

    $11M

    SRIWMitsubishi UFJ CapitalFund+Vesalius BiocapitalCell Innovation PartnersBoehringer Ingelheim

  4. Series C

    Nov 2014

    $25M

    Boehringer Ingelheim · LeadShireSRIWVesalius Biocapital · LeadSFPI-FPIMMitsui & Co. Global InvestmentVIVES Louvain Technology Fund

  5. Series B

    Mar 2012

    $23M

    SopartecBoehringer IngelheimNivelinvestShireLife Sciences Research PartnersVIVES Louvain Technology FundVesalius BiocapitalSambrinvestMitsui & Co. Global InvestmentSRIW

Team

John Tchelingerian

CEO & President

Bertrand Lellouche

GROUP CFO

Claude Dedry

COO

William Macias

Chief Medical Officer ad interim